| CAS ID: | 63527-52-6 |
| Molecular Formula: | C16H17N5O7S2 |
| Molecular Weight: | 455.5 g/mol |
| Monoisotopic Mass: | 455.0569 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | CEFOTAXIME SODIUM | Pretor | CLAFORAN | Cefcil | RU 24756 | HR 756 | CEFOTAXIME |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1 | See All |
| InChI Key: | GPRBEKHLDVQUJE-QSWIMTSFSA-N | |
| Smiles: | CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)C)\c3csc(N)n3 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01265173 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | December 23, 2010 | Last Verified | August 22, 2017 |
| Sponsor | Korea University | ||
Trial Record 2
| ClinicalTrial ID | NCT01820026 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | March 28, 2013 | Last Verified | May 29, 2015 |
| Sponsor | University of Roma La Sapienza | ||
| PubChem: | 5742673 |
| ChEMBL: | CHEMBL1730 |